Skip to content

Clinical trials

Fatty Liver trials in China with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Phase: Not applicable Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20212
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Unknown status2
Active, not recruiting1
Enrolling by invitation1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University1
Jinling Hospital, China1
Renmin Hospital of Wuhan University1
Shanghai Zhongshan Hospital1
Shengjing Hospital1
Sun Yat-sen University1
The Affiliated Hospital of Hangzhou Normal University1
The Third Xiangya Hospital of Central South University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver8
Non-alcoholic Fatty Liver Disease2
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Glucose Metabolism Disorders1
Liver Cirrhosis1
Liver Diseases, Alcoholic1
Metabolic Syndrome1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.